Introduction: Angina with no obstructive coronary artery disease (ANOCA) presents diagnostic and treatment challenges, significantly burdening healthcare resources. This study assessed emergency department (ED) visits and hospitalizations and factors associated with these outcomes following ANOCA and stable angina (SA) with obstructive coronary artery disease (CAD) diagnoses.
Methods: A retrospective cohort of individuals who had their first invasive cardiac catheterization for chest pain in Alberta from 2002 to 2017 was extracted retrospectively from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) database. Incidence rates (IRs) were calculated for ED visits and hospitalizations, while factors associated with these outcomes were analyzed using Cox models.
Results: Our analysis included 28,881 individuals (ANOCA, 36%). Two-year post-catheterization IRs of ED visits were 100.3-119.3 per 1,000 person-years for ANOCA and increased over time (unstandardized beta coefficient [b]=2.19 per biennium [95%CI 0.83-3.55];p=0.008); for SA with obstructive CAD the IRs were 209.3-240.2 per 1,000 person-years and remained stable (b=-1.83 per biennium [95% CI -5.73 to 1.70]; p=0.25). IRs of hospitalizations were 12.4-25.8 per 1,000 person-years and stable for ANOCA (b=-0.93 per biennium [95% CI -2.49-0.64];p=0.20); for SA with obstructive CAD, they were 106.4-171.4 per 1,000 person-years and decreased over time (b=-9.02 per biennium [95% CI -13.27 to -4.77; p=0.002). A previous history of heart failure was most associated with ED visits (HR= 1.74 [95% CI 1.41-2.14]; p<0.001) and hospitalizations (HR= 2.40 [95% CI 1.82-3.18]; p<0.001) for ANOCA.
Conclusions: ED visits for ANOCA have risen over time while hospitalizations remain stable, indicating a growing burden despite generally lower rates than SA with obstructive CAD. These findings underscore the need for more effective management strategies to address the significant morbidity and resource utilization in ANOCA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ahj.2025.02.021 | DOI Listing |
N Engl J Med
March 2025
Department of Disease Control, London School of Hygiene and Tropical Medicine, London.
Background: Hospital studies suggest that scrub typhus is a leading cause of severe undifferentiated fever in regions across Asia where the disease is endemic, but the population-based incidence of infection and illness has been little studied.
Methods: We conducted a population-based cohort study to assess epidemiologic and clinical characteristics of scrub typhus in 37 villages in Tamil Nadu, India, where the disease is highly endemic. Study participants were visited every 6 to 8 weeks over a period of 2 years; a venous blood sample was obtained from those who had had fever since the last visit.
Gen Psychiatr
March 2025
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: As the population in China rapidly ages, the prevalence of mild cognitive impairment (MCI) is increasing considerably. However, the causes of MCI vary. The continued lack of understanding of the various subtypes of MCI impedes the implementation of effective measures to reduce the risk of advancing to more severe cognitive diseases.
View Article and Find Full Text PDFBMJ Glob Health
March 2025
Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Introduction: Malaria remains a significant public health challenge globally, particularly in sub-Saharan Africa, where progress has stalled in recent years. Long-lasting insecticidal nets (LLINs) are a critical preventive tool against malaria. This study investigated the effectiveness of newer-generation LLINs following a universal coverage campaign in Uganda.
View Article and Find Full Text PDFJ Thromb Thrombolysis
March 2025
Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, 106 Zhongshan Road #2, Guangzhou, Guandong, 510080, China.
The reported incidence of arterial thromboembolism (ATE) and venous thromboembolism (VTE) after cancer varies. A meta-analysis was performed to define the incidence of thromboembolism (TE) in cancer patients. Articles were searched in PubMed and Embase from inception to November 1, 2023.
View Article and Find Full Text PDFAm J Transplant
March 2025
Division of Cancer Epidemiology and Genetics, National Cancer Institute, MD.
Belatacept is a selective T-cell co-stimulation blocker used in maintenance immunosuppression for kidney transplant recipients (KTRs), but evidence on cancer risk and other outcomes is limited. This retrospective cohort study used linked US transplant and cancer registry data on KTRs treated with belatacept (N=1514) or tacrolimus (N=7570) as initial maintenance therapy. We used multivariable Cox regression models to compare incidence of invasive cancer, cutaneous squamous cell carcinoma (cSCC), posttransplant lymphoproliferative disorder (PTLD), death, and graft failure/retransplantation (GF/RT) between belatacept and tacrolimus users.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!